Search research articles
Contact Us
Filters
Showing results (71-80 of 155) with videos related to
Page
of 16
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study
R C Seeger, C P Reynolds, R Gallego, et al.
Cancer Research
|
March 30, 1999
The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis
Y Sugiura, L Ma, B Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study
K K Matthay, J B Atkinson, D O Stram, et al.
Journal of Immunogenetics
|
June 1, 1984
A monoclonal antibody recognizing human Thy-1: distribution on human and non-human primate haematopoietic cells
K A Foon, R H Neubauer, C J Wikstrand, et al.
The New England Journal of Medicine
|
October 31, 1985
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
R C Seeger, G M Brodeur, H Sather, et al.
The New England Journal of Medicine
|
January 24, 1991
Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma
T J Moss, C P Reynolds, H N Sather, et al.
Cancer
|
July 15, 1986
Clinical implications of oncogene activation in human neuroblastomas
G M Brodeur, R C Seeger, H Sather, et al.
Cancer Research
|
September 15, 1990
Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors
P S Cohen, M J Cooper, L J Helman, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens
T J Moss, R C Seeger, A Kindler-Rohrborn, et al.
The American Journal of Pathology
|
August 4, 2001
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow
D S Hoon, C T Kuo, S Wen, et al.
Page
of 16
Search research articles
Search
Showing results (71-80 of 155) with videos related to
Sort By:
Page
of 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 19, 2000
Quantitative tumor cell content of bone marrow and blood as a predictor of outcome in stage IV neuroblastoma: a Children's Cancer Group Study
R C Seeger, C P Reynolds, R Gallego, et al.
Cancer Research
|
March 30, 1999
The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis
Y Sugiura, L Ma, B Sun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 1, 1993
Patterns of relapse after autologous purged bone marrow transplantation for neuroblastoma: a Childrens Cancer Group pilot study
K K Matthay, J B Atkinson, D O Stram, et al.
Journal of Immunogenetics
|
June 1, 1984
A monoclonal antibody recognizing human Thy-1: distribution on human and non-human primate haematopoietic cells
K A Foon, R H Neubauer, C J Wikstrand, et al.
The New England Journal of Medicine
|
October 31, 1985
Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
R C Seeger, G M Brodeur, H Sather, et al.
The New England Journal of Medicine
|
January 24, 1991
Prognostic value of immunocytologic detection of bone marrow metastases in neuroblastoma
T J Moss, C P Reynolds, H N Sather, et al.
Cancer
|
July 15, 1986
Clinical implications of oncogene activation in human neuroblastomas
G M Brodeur, R C Seeger, H Sather, et al.
Cancer Research
|
September 15, 1990
Neuropeptide Y expression in the developing adrenal gland and in childhood neuroblastoma tumors
P S Cohen, M J Cooper, L J Helman, et al.
Progress in Clinical and Biological Research
|
January 1, 1985
Immunohistologic detection and phenotyping of neuroblastoma cells in bone marrow using cytoplasmic neuron specific enolase and cell surface antigens
T J Moss, R C Seeger, A Kindler-Rohrborn, et al.
The American Journal of Pathology
|
August 4, 2001
Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow
D S Hoon, C T Kuo, S Wen, et al.
Page
of 16